Publications by authors named "Erica Lafoz"

Claim this Profile
I
Impact of lifestyle interventions targeting physical exercise and caloric intake on cirrhosis regression in rats.
Erica Lafoz, Genís Campreciós, Héctor García-Calderó, Aina Anton, Marina Vilaseca

Am J Physiol Gastrointest Liver Physiol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spermidine Supplementation Protects the Liver Endothelium from Liver Damage in Mice.
Genís Campreciós, Maria Ruart, Aina Anton, Nuria Suárez-Herrera, Carla Montironi, Erica Lafoz

Nutrients· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoimmune biomarkers in porto-sinusoidal vascular disease: Potential role in its diagnosis and pathophysiology.
Eira Cerda Reyes, Europa Azucena González-Navarro, Marta Magaz, Guillermo Muñoz-Sánchez, Alba Diaz, Erica Lafoz

Liver Int· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Endothelium as a Driver of Liver Fibrosis and Regeneration.
Erica Lafoz, Maria Ruart, Aina Anton, Anna Oncins, Virginia Hernández-Gea

Cells· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aging Influences Hepatic Microvascular Biology and Liver Fibrosis in Advanced Chronic Liver Disease.
Raquel Maeso-Díaz, Martí Ortega-Ribera, Erica Lafoz, Juan José Lozano, Anna Baiges

Aging Dis· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simvastatin Prevents Progression of Acute on Chronic Liver Failure in Rats With Cirrhosis and Portal Hypertension.
Dinesh Mani Tripathi, Marina Vilaseca, Erica Lafoz, Héctor Garcia-Calderó, Gabriela Viegas Haute

Gastroenterology· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitochondria-targeted antioxidant mitoquinone deactivates human and rat hepatic stellate cells and reduces portal hypertension in cirrhotic rats.
Marina Vilaseca, Héctor García-Calderó, Erica Lafoz, Maria Ruart, Cristina Isabel López-Sanjurjo

Liver Int· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The anticoagulant rivaroxaban lowers portal hypertension in cirrhotic rats mainly by deactivating hepatic stellate cells.
Marina Vilaseca, Héctor García-Calderó, Erica Lafoz, Oihane García-Irigoyen, Matías A Avila

Hepatology· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enoxaparin reduces hepatic vascular resistance and portal pressure in cirrhotic rats.
Federica Cerini, Marina Vilaseca, Erica Lafoz, Oihane García-Irigoyen, Héctor García-Calderó

J Hepatol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin reduces hepatic resistance and portal pressure in cirrhotic rats.
Dinesh M Tripathi, Eva Erice, Erica Lafoz, Héctor García-Calderó, Shiv K Sarin

Am J Physiol Gastrointest Liver Physiol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis